The company's financial position appears increasingly vulnerable as the debt-to-equity ratio climbed to 2.25 in 2026Q2, significantly higher than historical levels near 0.75.
| Total Current Assets | 294.28M | 308.31M | 408.67M | 397.11M | 297.71M | 211.49M | 164.69M | 98.21M | 85.34M | 87.77M |
| Cash & Short-Term Investments | 12.58M | 34.74M | 56.17M | 60.05M | 38.61M | 46.78M | 55.96M | 3.81M | 2.23M | 1.68M |
| Cash Only | 11.06M | 32.7M | 44.47M | 48.13M | 33.48M | 36.05M | 27.16M | 3.45M | 2.22M | 1.68M |
| Short-Term Investments | 1.52M | 2.04M | 11.7M | 11.92M | 5.14M | 10.74M | 28.8M | 356.23K | 12.53K | 4.28K |
| Accounts Receivable | 165.84M | 177.75M | 216.03M | 185.32M | 128.08M | 99.15M | 77.84M | 59.24M | 52.89M | 41.68M |
| Days Sales Outstanding | 228.28 | 194.66 | 169.64 | 161.26 | 142.33 | 175.08 | 164.85 | 134.87 | 144.61 | 162.33 |
| Inventory | 67.15M | 89.99M | 126.22M | 140.57M | 126.1M | 63.35M | 30.77M | 27.59M | 19.37M | 31.34M |
| Days Inventory Outstanding | 177 | 161.72 | 162.66 | 214.51 | 227.84 | 199.66 | 120.93 | 116.18 | 91.69 | 191.09 |
| Other Current Assets | 42.36M | 0 | 0 | 212.7K | 265.12K | 425.98K | 128.65K | 7.36M | 10.86M | 12.8M |
| Total Non-Current Assets | 266.08M | 455.33M | 443.88M | 420.94M | 220.52M | 183.1M | 132.87M | 144.26M | 111.3M | 152.1M |
| Property, Plant & Equipment | 72.06M | 90.95M | 86.18M | 81.79M | 62.05M | 49.28M | 42.63M | 43.83M | 40.18M | 46.22M |
| Fixed Asset Turnover | 3.31x | 3.66x | 5.39x | 5.13x | 5.29x | 4.19x | 4.04x | 3.66x | 3.32x | 2.03x |
| Goodwill | 36.07M | 112.16M | 112.16M | 112.16M | 36.07M | 28.75M | 25.53M | 29.8M | 14.44M | 25.08M |
| Intangible Assets | 87.29M | 181.17M | 176.89M | 173.78M | 76.7M | 67.34M | 35.33M | 39.62M | 26.66M | 42.06M |
| Long-Term Investments | 183.63M | 39.37M | 40.42M | 39.74M | 39.17M | 31.75M | 26.35M | 25.7M | 19.32M | 32.88M |
| Other Non-Current Assets | 25.66M | 26.76M | 18.53M | 6.15M | 2.5M | 2.69M | 334.73K | 1.56M | 5.11M | 5.87M |
| Total Assets | 560.36M | 763.65M | 852.55M | 818.06M | 518.22M | 394.59M | 297.56M | 242.47M | 196.64M | 239.87M |
| Asset Turnover | 0.40x | 0.44x | 0.55x | 0.51x | 0.63x | 0.52x | 0.58x | 0.66x | 0.68x | 0.39x |
| Asset Growth % | -58.83% | -10.43% | 4.22% | 57.86% | 31.33% | 32.61% | 22.72% | 23.31% | -18.02% | - |
| Total Current Liabilities | 328.64M | 337.99M | 329.31M | 298.71M | 222.67M | 168.04M | 130.61M | 116.46M | 118.68M | 69.39M |
| Accounts Payable | 82.54M | 91.58M | 161.93M | 146.29M | 124.41M | 69.31M | 54.79M | 38.66M | 26.08M | 22.28M |
| Days Payables Outstanding | 201.52 | 164.58 | 208.67 | 223.23 | 224.77 | 218.42 | 215.37 | 162.78 | 123.48 | 135.86 |
| Short-Term Debt | 194.42M | 222M | 136.75M | 107.64M | 71.3M | 76.79M | 64.39M | 66.09M | 65.03M | 33.57M |
| Deferred Revenue (Current) | 12.97M | 4.28M | 3.92M | 24.88M | 5.9M | 6.28M | 2.87M | 1.08M | 1.02M | 0 |
| Other Current Liabilities | 33.12M | 7.94M | 11.96M | 5.93M | 10.67M | 2.79M | 2.5M | 4.49M | 22.84M | 7.65M |
| Current Ratio | 0.90x | 0.91x | 1.24x | 1.33x | 1.34x | 1.26x | 1.26x | 0.84x | 0.72x | 1.26x |
| Quick Ratio | 0.69x | 0.65x | 0.86x | 0.86x | 0.77x | 0.88x | 1.03x | 0.61x | 0.56x | 0.81x |
| Cash Conversion Cycle | 203.76 | 191.81 | 123.63 | 152.54 | 145.39 | 156.33 | 70.41 | 88.27 | 112.81 | 217.56 |
| Total Non-Current Liabilities | 125.11M | 130.44M | 171.86M | 188.85M | 137.26M | 136.26M | 106.9M | 63.91M | 44.82M | 90.74M |
| Long-Term Debt | 34.16M | 38.2M | 122.91M | 135.88M | 86.74M | 96.65M | 84.96M | 36.62M | 25.25M | 40.27M |
| Capital Lease Obligations | 41.31M | 9.53M | 8.16M | 10.03M | 10.34M | 390.41K | 444.71K | 462.87K | 454.26K | 678.99K |
| Deferred Tax Liabilities | 116.28M | 30.12M | 35M | 35.79M | 29.01M | 25.7M | 16.86M | 21.1M | 13.59M | 0 |
| Other Non-Current Liabilities | 54M | 51.15M | 3.86M | 5.09M | 11.18M | 13.52M | 4.64M | 5.72M | 19.12M | 49.79M |
| Total Liabilities | 453.75M | 468.43M | 501.17M | 487.56M | 359.92M | 304.3M | 237.51M | 180.37M | 163.51M | 160.13M |
| Total Debt | 239.46M | 276.61M | 270.95M | 257.41M | 169.79M | 174.58M | 149.79M | 103.56M | 91.02M | 74.99M |
| Net Debt | 228.39M | 243.91M | 226.47M | 209.28M | 136.31M | 138.53M | 122.63M | 100.11M | 88.8M | 73.31M |
| Debt / Equity | 2.25x | 0.94x | 0.77x | 0.78x | 1.07x | 1.93x | 2.49x | 1.67x | 2.75x | 0.94x |
| Debt / EBITDA | 12.58x | 20.20x | 4.10x | 3.50x | 3.46x | 3.91x | 3.41x | 2.81x | 4.53x | 19.23x |
| Net Debt / EBITDA | 12.00x | 17.81x | 3.43x | 2.84x | 2.78x | 3.10x | 2.79x | 2.71x | 4.42x | 18.80x |
| Interest Coverage | -0.12x | -0.08x | 1.27x | 2.23x | 2.16x | 1.76x | 1.33x | 0.57x | - | - |
| Total Equity | 106.62M | 295.22M | 351.38M | 330.5M | 158.3M | 90.29M | 60.05M | 62.09M | 33.13M | 79.74M |
| Equity Growth % | -105.08% | -15.98% | 6.32% | 108.78% | 75.32% | 50.37% | -3.3% | 87.41% | -58.45% | - |
| Book Value per Share | 1.68 | 4.67 | 5.53 | 5.23 | 3.74 | 2.30 | 1.65 | 2.04 | 1.18 | 2.84 |
| Total Shareholders' Equity | 73.77M | 262.81M | 315.3M | 298.85M | 127.61M | 67.74M | 45.48M | 47.3M | 13.71M | 38.34M |
| Common Stock | 6.5K | 6.5K | 6.5K | 6.49K | 4.64K | 4.16K | 3.61K | 3.61K | 2.81K | 2.81K |
| Retained Earnings | -255.41M | -65.04M | -9.63M | -13.9M | -32.68M | -25.48M | -18.61M | -21.97M | -26.15M | -15.11M |
| Treasury Stock | -25.17M | -32.21M | -31.29M | -30.55M | -3.53M | -4.45M | -30.91K | 0 | 0 | 0 |
| Accumulated OCI | 61.65K | 91.81K | 633.49K | 1.12M | 1.98M | -27.37M | -32.37M | -27.22M | -28.27M | -5.31M |
| Minority Interest | 32.85M | 32.41M | 36.08M | 31.65M | 30.68M | 22.55M | 14.57M | 14.79M | 19.42M | 41.4M |
Argentine sovereign liquidity constraints
As reported in recent financial filings, the company's equity base has deteriorated significantly, plummeting from $314.0M in 2024Q4 to just $73.8M by 2026Q2, a trend that reflects the compounding impact of persistent net losses and the erosion of retained earnings over the observed period.
The rapid decline in shareholder equity suggests that the company is struggling to maintain its capital base amidst ongoing operational losses. Investors should monitor whether this trajectory indicates a need for future dilutive financing to stabilize the balance sheet.
Based on the latest quarterly data, the debt-to-equity ratio has surged to 2.25 in 2026Q2 from a historical average near 0.75, indicating that the company's reliance on debt financing has intensified precisely as its equity cushion has thinned, warranting close scrutiny of refinancing capabilities.
The sharp increase in leverage appears to be a response to liquidity pressures rather than a strategic capital allocation decision. This shift suggests that the company's debt service capacity may be increasingly constrained by its inability to generate consistent, positive operating cash flows.
According to the 2026Q2 balance sheet, the current ratio has compressed to 0.90, falling below the critical 1.0 threshold, which implies that the company's short-term assets may no longer be sufficient to cover its immediate liabilities without significant operational or external intervention.
The decline in the current ratio highlights a tightening liquidity environment that leaves little room for error in managing working capital. This trend suggests that the company may face increasing difficulty in meeting its short-term obligations if revenue contraction persists.
As indicated by the provided financial data, the company carries $36.1M in goodwill as of 2026Q2, a figure that warrants investigation given the recent 28.3% revenue decline and the potential for future impairment charges to further depress the already fragile equity position.
The presence of significant intangible assets on the balance sheet during a period of operational contraction suggests that the carrying value of past acquisitions may be overstated. Investors should consider the risk that future write-downs could exacerbate the current downward pressure on the company's net worth.
Quick answers to the most common questions about buying BIOX stock.
As of 2025, Bioceres Crop Solutions Corp. (BIOX) had total assets of $763.6M including $308.3M in current assets.
Bioceres Crop Solutions Corp. (BIOX) carries total debt of $276.6M, offset by $34.7M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Bioceres Crop Solutions Corp. (BIOX) has total shareholders' equity (book value) of $262.8M ($4.67 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Bioceres Crop Solutions Corp. (BIOX) reported a current ratio of 0.91x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.